간성 뇌증 (Korean Wikipedia)

Analysis of information sources in references of the Wikipedia article "간성 뇌증" in Korean language version.

refsWebsite

Global rank Korean rank

22nih.gov

4^th place

21doi.org

2^nd place

3^rd place

6semanticscholar.org

11^th place

310^th place

2web.archive.org

1^st place

2worldcat.org

5^th place

11^th place

2wiley.com

222^nd place

164^th place

1clevelandclinic.org

4,925^th place

4,695^th place

1merckmanuals.com

3,097^th place

1,083^rd place

1books.google.com

3^rd place

9^th place

1archive.org

6^th place

18^th place

1amc.seoul.kr

low place

933^rd place

1europepmc.org

8,929^th place

7,578^th place

1archive.today

14^th place

15^th place

1ucl.ac.uk

1,306^th place

960^th place

amc.seoul.kr

“목정맥경유간속문맥전신순환지름술”. 《서울아산병원》. 2022년 9월 17일에 확인함.

archive.org

Chung RT, Podolsky DK (2005). 〈Cirrhosis and its complications〉. Kasper DL, Braunwald E, Fauci AS, 외. 《Harrison's Principles of Internal Medicine》 16판. New York, NY: McGraw-Hill. 1858–69쪽. ISBN 978-0-07-139140-5.

archive.today

Polson J, Lee WM (May 2005). “AASLD position paper: the management of acute liver failure”. 《Hepatology》 41 (5): 1179–97. doi:10.1002/hep.20703. PMID 15841455. S2CID 6216605. 2012년 12월 16일에 원본 문서에서 보존된 문서.

books.google.com

Ferri, Fred F. (2017). 《Ferri's Clinical Advisor 2018 E-Book: 5 Books in 1》 (영어). Elsevier Health Sciences. 577쪽. ISBN 9780323529570. 2017년 7월 30일에 원본 문서에서 보존된 문서.

clevelandclinic.org

my.clevelandclinic.org

“Hepatic encephalopathy”. Clevelandclinic. 2022년 6월 9일에 확인함.

doi.org

dx.doi.org

Wijdicks, EF (2016년 10월 27일). “Hepatic Encephalopathy.”. 《The New England Journal of Medicine》 375 (17): 1660–1670. doi:10.1056/NEJMra1600561. PMID 27783916.
Cash WJ, McConville P, McDermott E, McCormick PA, Callender ME, McDougall NI (January 2010). “Current concepts in the assessment and treatment of hepatic encephalopathy”. 《QJM》 103 (1): 9–16. doi:10.1093/qjmed/hcp152. PMID 19903725.
Sundaram V, Shaikh OS (July 2009). “Hepatic encephalopathy: pathophysiology and emerging therapies”. 《Med. Clin. North Am.》 93 (4): 819–36, vii. doi:10.1016/j.mcna.2009.03.009. PMID 19577116.
Khan S, Tudur Smith C, Williamson P, Sutton R (2006). “Portosystemic shunts versus endoscopic therapy for variceal rebleeding in patients with cirrhosis”. 《Cochrane Database Syst Rev》 (4): CD000553. doi:10.1002/14651858.CD000553.pub2. PMC 7045742. PMID 17054131.
Saab S, Nieto JM, Lewis SK, Runyon BA (2006). “TIPS versus paracentesis for cirrhotic patients with refractory ascites”. 《Cochrane Database Syst Rev》 2010 (4): CD004889. doi:10.1002/14651858.CD004889.pub2. PMC 8855742. PMID 17054221.
Ryan JM, Shawcross DL (2011). “Hepatic encephalopathy”. 《Medicine》 39 (10): 617–620. doi:10.1016/j.mpmed.2011.07.008.
Thumburu, KK; Dhiman, RK; Vasishta, RK; Chakraborti, A; Butterworth, RF; Beauchesne, E; Desjardins, P; Goyal, S; Sharma, N; Duseja, A; Chawla, Y (Mar 2014). “Expression of astrocytic genes coding for proteins implicated in neural excitation and brain edema is altered after acute liver failure.”. 《Journal of Neurochemistry》 128 (5): 617–27. doi:10.1111/jnc.12511. PMID 24164438. S2CID 21367707.
Ferenci P, Lockwood A, Mullen K, Tarter R, Weissenborn K, Blei A (2002). “Hepatic encephalopathy--definition, nomenclature, diagnosis, and quantification: final report of the working party at the 11th World Congresses of Gastroenterology, Vienna, 1998”. 《Hepatology》 35 (3): 716–21. doi:10.1053/jhep.2002.31250. PMID 11870389. S2CID 7929620. 전체 텍스트 PDF
Randolph C, Hilsabeck R, Kato A, 외. (May 2009). “Neuropsychological assessment of hepatic encephalopathy: ISHEN practice guidelines”. 《Liver Int.》 29 (5): 629–35. doi:10.1111/j.1478-3231.2009.02009.x. PMID 19302444. S2CID 30313260.
Bajaj JS (March 2010). “Review article: the modern management of hepatic encephalopathy”. 《Aliment. Pharmacol. Ther.》 31 (5): 537–47. doi:10.1111/j.1365-2036.2009.04211.x. PMID 20002027. S2CID 10976362.
Randolph C, Tierney MC, Mohr E, Chase TN (June 1998). “The Repeatable Battery for the Assessment of Neuropsychological Status (RBANS): preliminary clinical validity”. 《J Clin Exp Neuropsychol》 20 (3): 310–9. doi:10.1076/jcen.20.3.310.823. PMID 9845158.
Weissenborn K, Ennen JC, Schomerus H, Rückert N, Hecker H (May 2001). “Neuropsychological characterization of hepatic encephalopathy”. 《J. Hepatol.》 34 (5): 768–73. doi:10.1016/S0168-8278(01)00026-5. PMID 11434627.
Polson J, Lee WM (May 2005). “AASLD position paper: the management of acute liver failure”. 《Hepatology》 41 (5): 1179–97. doi:10.1002/hep.20703. PMID 15841455. S2CID 6216605. 2012년 12월 16일에 원본 문서에서 보존된 문서.
Gluud, Lise Lotte; Vilstrup, Hendrik; Morgan, Marsha Y. (2016년 5월 6일). “Non-absorbable disaccharides versus placebo/no intervention and lactulose versus lactitol for the prevention and treatment of hepatic encephalopathy in people with cirrhosis”. 《The Cochrane Database of Systematic Reviews》 2016 (5): CD003044. doi:10.1002/14651858.CD003044.pub4. ISSN 1469-493X. PMC 7004252. PMID 27153247.
Ferenci, P (May 2017). “Hepatic encephalopathy.”. 《Gastroenterology Report》 5 (2): 138–147. doi:10.1093/gastro/gox013. PMC 5421503. PMID 28533911.
Goh, Ee Teng; Stokes, Caroline S.; Sidhu, Sandeep S.; Vilstrup, Hendrik; Gluud, Lise Lotte; Morgan, Marsha Y. (2018년 5월 15일). “L-ornithine L-aspartate for prevention and treatment of hepatic encephalopathy in people with cirrhosis” (PDF). 《The Cochrane Database of Systematic Reviews》 5 (6): CD012410. doi:10.1002/14651858.CD012410.pub2. ISSN 1469-493X. PMC 6494563. PMID 29762873.
Kircheiscorresponding, G; Lüth, S (2019). “Pharmacokinetic and Pharmacodynamic Properties of l-Ornithine l-Aspartate (LOLA) in Hepatic Encephalopathy”. 《Drugs》 79 (1): 23–29. doi:10.1007/s40265-018-1023-2. PMC 6416235. PMID 30706424.
Sherlock S, Summerskill WH, White LP, Phear EA (September 1954). “Portal-systemic encephalopathy; neurological complications of liver disease”. 《Lancet》 264 (6836): 453–7. doi:10.1016/S0140-6736(54)91874-7. PMID 13193045.
Last PM, Sherlock S (February 1960). “Systemic absorption of orally administered neomycin in liver disease”. 《N. Engl. J. Med.》 262 (8): 385–9. doi:10.1056/NEJM196002252620803. PMID 14414396.
Conn HO, Leevy CM, Vlahcevic ZR, 외. (1977). “Comparison of lactulose and neomycin in the treatment of chronic portal-systemic encephalopathy. A double blind controlled trial”. 《Gastroenterology》 72 (4 Pt 1): 573–83. doi:10.1016/S0016-5085(77)80135-2. PMID 14049.
Boyer JL, Garcia-Tsao G, Groszmann RJ (February 2012). “In Memoriam: Harold O. Conn, M.D.”. 《Hepatology》 55 (2): 658–9. doi:10.1002/hep.25550. S2CID 85090164.

europepmc.org

Ferenci P, Lockwood A, Mullen K, Tarter R, Weissenborn K, Blei A (2002). “Hepatic encephalopathy--definition, nomenclature, diagnosis, and quantification: final report of the working party at the 11th World Congresses of Gastroenterology, Vienna, 1998”. 《Hepatology》 35 (3): 716–21. doi:10.1053/jhep.2002.31250. PMID 11870389. S2CID 7929620. 전체 텍스트 PDF

merckmanuals.com

“Portosystemic Encephalopathy - Hepatic and Biliary Disorders”. 《Merck Manuals Professional Edition》 (캐나다 영어). 2019년 9월 25일에 확인함.

nih.gov

ncbi.nlm.nih.gov

Wijdicks, EF (2016년 10월 27일). “Hepatic Encephalopathy.”. 《The New England Journal of Medicine》 375 (17): 1660–1670. doi:10.1056/NEJMra1600561. PMID 27783916.
Cash WJ, McConville P, McDermott E, McCormick PA, Callender ME, McDougall NI (January 2010). “Current concepts in the assessment and treatment of hepatic encephalopathy”. 《QJM》 103 (1): 9–16. doi:10.1093/qjmed/hcp152. PMID 19903725.
Starr, SP; Raines, D (2011년 12월 15일). “Cirrhosis: diagnosis, management, and prevention.”. 《American Family Physician》 84 (12): 1353–9. PMID 22230269.
Sundaram V, Shaikh OS (July 2009). “Hepatic encephalopathy: pathophysiology and emerging therapies”. 《Med. Clin. North Am.》 93 (4): 819–36, vii. doi:10.1016/j.mcna.2009.03.009. PMID 19577116.
Khan S, Tudur Smith C, Williamson P, Sutton R (2006). “Portosystemic shunts versus endoscopic therapy for variceal rebleeding in patients with cirrhosis”. 《Cochrane Database Syst Rev》 (4): CD000553. doi:10.1002/14651858.CD000553.pub2. PMC 7045742. PMID 17054131.
Saab S, Nieto JM, Lewis SK, Runyon BA (2006). “TIPS versus paracentesis for cirrhotic patients with refractory ascites”. 《Cochrane Database Syst Rev》 2010 (4): CD004889. doi:10.1002/14651858.CD004889.pub2. PMC 8855742. PMID 17054221.
Thumburu, KK; Dhiman, RK; Vasishta, RK; Chakraborti, A; Butterworth, RF; Beauchesne, E; Desjardins, P; Goyal, S; Sharma, N; Duseja, A; Chawla, Y (Mar 2014). “Expression of astrocytic genes coding for proteins implicated in neural excitation and brain edema is altered after acute liver failure.”. 《Journal of Neurochemistry》 128 (5): 617–27. doi:10.1111/jnc.12511. PMID 24164438. S2CID 21367707.
Ferenci P, Lockwood A, Mullen K, Tarter R, Weissenborn K, Blei A (2002). “Hepatic encephalopathy--definition, nomenclature, diagnosis, and quantification: final report of the working party at the 11th World Congresses of Gastroenterology, Vienna, 1998”. 《Hepatology》 35 (3): 716–21. doi:10.1053/jhep.2002.31250. PMID 11870389. S2CID 7929620. 전체 텍스트 PDF
Randolph C, Hilsabeck R, Kato A, 외. (May 2009). “Neuropsychological assessment of hepatic encephalopathy: ISHEN practice guidelines”. 《Liver Int.》 29 (5): 629–35. doi:10.1111/j.1478-3231.2009.02009.x. PMID 19302444. S2CID 30313260.
Bajaj JS (March 2010). “Review article: the modern management of hepatic encephalopathy”. 《Aliment. Pharmacol. Ther.》 31 (5): 537–47. doi:10.1111/j.1365-2036.2009.04211.x. PMID 20002027. S2CID 10976362.
Randolph C, Tierney MC, Mohr E, Chase TN (June 1998). “The Repeatable Battery for the Assessment of Neuropsychological Status (RBANS): preliminary clinical validity”. 《J Clin Exp Neuropsychol》 20 (3): 310–9. doi:10.1076/jcen.20.3.310.823. PMID 9845158.
Weissenborn K, Ennen JC, Schomerus H, Rückert N, Hecker H (May 2001). “Neuropsychological characterization of hepatic encephalopathy”. 《J. Hepatol.》 34 (5): 768–73. doi:10.1016/S0168-8278(01)00026-5. PMID 11434627.
Polson J, Lee WM (May 2005). “AASLD position paper: the management of acute liver failure”. 《Hepatology》 41 (5): 1179–97. doi:10.1002/hep.20703. PMID 15841455. S2CID 6216605. 2012년 12월 16일에 원본 문서에서 보존된 문서.
Gluud, Lise Lotte; Vilstrup, Hendrik; Morgan, Marsha Y. (2016년 5월 6일). “Non-absorbable disaccharides versus placebo/no intervention and lactulose versus lactitol for the prevention and treatment of hepatic encephalopathy in people with cirrhosis”. 《The Cochrane Database of Systematic Reviews》 2016 (5): CD003044. doi:10.1002/14651858.CD003044.pub4. ISSN 1469-493X. PMC 7004252. PMID 27153247.
Ferenci, P (May 2017). “Hepatic encephalopathy.”. 《Gastroenterology Report》 5 (2): 138–147. doi:10.1093/gastro/gox013. PMC 5421503. PMID 28533911.
Goh, Ee Teng; Stokes, Caroline S.; Sidhu, Sandeep S.; Vilstrup, Hendrik; Gluud, Lise Lotte; Morgan, Marsha Y. (2018년 5월 15일). “L-ornithine L-aspartate for prevention and treatment of hepatic encephalopathy in people with cirrhosis” (PDF). 《The Cochrane Database of Systematic Reviews》 5 (6): CD012410. doi:10.1002/14651858.CD012410.pub2. ISSN 1469-493X. PMC 6494563. PMID 29762873.
Kircheiscorresponding, G; Lüth, S (2019). “Pharmacokinetic and Pharmacodynamic Properties of l-Ornithine l-Aspartate (LOLA) in Hepatic Encephalopathy”. 《Drugs》 79 (1): 23–29. doi:10.1007/s40265-018-1023-2. PMC 6416235. PMID 30706424.
Summerskill WH, Davidson EA, Sherlock S, Steiner RE (April 1956). “The neuropsychiatric syndrome associated with hepatic cirrhosis and an extensive portal collateral circulation”. 《Q. J. Med.》 25 (98): 245–66. PMID 13323252.
Sherlock S, Summerskill WH, White LP, Phear EA (September 1954). “Portal-systemic encephalopathy; neurological complications of liver disease”. 《Lancet》 264 (6836): 453–7. doi:10.1016/S0140-6736(54)91874-7. PMID 13193045.
Last PM, Sherlock S (February 1960). “Systemic absorption of orally administered neomycin in liver disease”. 《N. Engl. J. Med.》 262 (8): 385–9. doi:10.1056/NEJM196002252620803. PMID 14414396.
Conn HO, Leevy CM, Vlahcevic ZR, 외. (1977). “Comparison of lactulose and neomycin in the treatment of chronic portal-systemic encephalopathy. A double blind controlled trial”. 《Gastroenterology》 72 (4 Pt 1): 573–83. doi:10.1016/S0016-5085(77)80135-2. PMID 14049.

rarediseases.info.nih.gov

“Hepatic encephalopathy”. 《GARD》 (영어). 2016. 2017년 7월 5일에 원본 문서에서 보존된 문서. 2017년 7월 30일에 확인함.

semanticscholar.org

api.semanticscholar.org

Thumburu, KK; Dhiman, RK; Vasishta, RK; Chakraborti, A; Butterworth, RF; Beauchesne, E; Desjardins, P; Goyal, S; Sharma, N; Duseja, A; Chawla, Y (Mar 2014). “Expression of astrocytic genes coding for proteins implicated in neural excitation and brain edema is altered after acute liver failure.”. 《Journal of Neurochemistry》 128 (5): 617–27. doi:10.1111/jnc.12511. PMID 24164438. S2CID 21367707.
Ferenci P, Lockwood A, Mullen K, Tarter R, Weissenborn K, Blei A (2002). “Hepatic encephalopathy--definition, nomenclature, diagnosis, and quantification: final report of the working party at the 11th World Congresses of Gastroenterology, Vienna, 1998”. 《Hepatology》 35 (3): 716–21. doi:10.1053/jhep.2002.31250. PMID 11870389. S2CID 7929620. 전체 텍스트 PDF
Randolph C, Hilsabeck R, Kato A, 외. (May 2009). “Neuropsychological assessment of hepatic encephalopathy: ISHEN practice guidelines”. 《Liver Int.》 29 (5): 629–35. doi:10.1111/j.1478-3231.2009.02009.x. PMID 19302444. S2CID 30313260.
Bajaj JS (March 2010). “Review article: the modern management of hepatic encephalopathy”. 《Aliment. Pharmacol. Ther.》 31 (5): 537–47. doi:10.1111/j.1365-2036.2009.04211.x. PMID 20002027. S2CID 10976362.
Polson J, Lee WM (May 2005). “AASLD position paper: the management of acute liver failure”. 《Hepatology》 41 (5): 1179–97. doi:10.1002/hep.20703. PMID 15841455. S2CID 6216605. 2012년 12월 16일에 원본 문서에서 보존된 문서.
Boyer JL, Garcia-Tsao G, Groszmann RJ (February 2012). “In Memoriam: Harold O. Conn, M.D.”. 《Hepatology》 55 (2): 658–9. doi:10.1002/hep.25550. S2CID 85090164.

ucl.ac.uk

discovery.ucl.ac.uk

Goh, Ee Teng; Stokes, Caroline S.; Sidhu, Sandeep S.; Vilstrup, Hendrik; Gluud, Lise Lotte; Morgan, Marsha Y. (2018년 5월 15일). “L-ornithine L-aspartate for prevention and treatment of hepatic encephalopathy in people with cirrhosis” (PDF). 《The Cochrane Database of Systematic Reviews》 5 (6): CD012410. doi:10.1002/14651858.CD012410.pub2. ISSN 1469-493X. PMC 6494563. PMID 29762873.

web.archive.org

“Hepatic encephalopathy”. 《GARD》 (영어). 2016. 2017년 7월 5일에 원본 문서에서 보존된 문서. 2017년 7월 30일에 확인함.
Ferri, Fred F. (2017). 《Ferri's Clinical Advisor 2018 E-Book: 5 Books in 1》 (영어). Elsevier Health Sciences. 577쪽. ISBN 9780323529570. 2017년 7월 30일에 원본 문서에서 보존된 문서.

wiley.com

aasldpubs.onlinelibrary.wiley.com

Ferenci P, Lockwood A, Mullen K, Tarter R, Weissenborn K, Blei A (2002). “Hepatic encephalopathy--definition, nomenclature, diagnosis, and quantification: final report of the working party at the 11th World Congresses of Gastroenterology, Vienna, 1998”. 《Hepatology》 35 (3): 716–21. doi:10.1053/jhep.2002.31250. PMID 11870389. S2CID 7929620. 전체 텍스트 PDF

www3.interscience.wiley.com

Polson J, Lee WM (May 2005). “AASLD position paper: the management of acute liver failure”. 《Hepatology》 41 (5): 1179–97. doi:10.1002/hep.20703. PMID 15841455. S2CID 6216605. 2012년 12월 16일에 원본 문서에서 보존된 문서.

worldcat.org

Gluud, Lise Lotte; Vilstrup, Hendrik; Morgan, Marsha Y. (2016년 5월 6일). “Non-absorbable disaccharides versus placebo/no intervention and lactulose versus lactitol for the prevention and treatment of hepatic encephalopathy in people with cirrhosis”. 《The Cochrane Database of Systematic Reviews》 2016 (5): CD003044. doi:10.1002/14651858.CD003044.pub4. ISSN 1469-493X. PMC 7004252. PMID 27153247.
Goh, Ee Teng; Stokes, Caroline S.; Sidhu, Sandeep S.; Vilstrup, Hendrik; Gluud, Lise Lotte; Morgan, Marsha Y. (2018년 5월 15일). “L-ornithine L-aspartate for prevention and treatment of hepatic encephalopathy in people with cirrhosis” (PDF). 《The Cochrane Database of Systematic Reviews》 5 (6): CD012410. doi:10.1002/14651858.CD012410.pub2. ISSN 1469-493X. PMC 6494563. PMID 29762873.